` VVEO3 (CM Hospitalar SA) vs BOVESPA Comparison - Alpha Spread

VVEO3
vs
B
BOVESPA

Over the past 12 months, VVEO3 has underperformed BOVESPA, delivering a return of -15% compared to the BOVESPA's +31% growth.

Stocks Performance
VVEO3 vs BOVESPA

Loading
VVEO3
BOVESPA
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
VVEO3 vs BOVESPA

Loading
VVEO3
BOVESPA
Difference
www.alphaspread.com

Performance By Year
VVEO3 vs BOVESPA

Loading
VVEO3
BOVESPA
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
CM Hospitalar SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

CM Hospitalar SA
Glance View

Market Cap
489.8m BRL
Industry
Health Care

CM Hospitalar SA engages in the provision of healthcare services. The company is headquartered in Ribeirao Preto, Sao Paulo and currently employs 6,000 full-time employees. The company went IPO on 2021-08-09. The firm operates mainly in export, import, production, representation, storage, distribution, and shipment of medicines, including special control and wholesale trade in general, acting mainly in the trade in health products, as a middleman between industries and hospitals, clinics, home cares and health institutions in the private and public market, in addition to participating in other investments. The company operates throughout Brazil with a commercial and logistical structure. The firm's medium and long-term planning encompasses the acquisition of companies from the segment and an important commercial strengthening throughout Brazil, expanding its position in the distribution of medicines and hospital supplies.

VVEO3 Intrinsic Value
10.44 BRL
Undervaluation 85%
Intrinsic Value
Price
Back to Top